Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Tianyin Pharma Announces Two TCM Product Approvals

publication date: Dec 1, 2009
Tianyin Pharmaceutical Co. received SFDA approval for two TCM products. Pediatric Fever and Cough Oral Liquid is a generic prescription TCM that treats respiratory tract infections and influenza in children. The second product, Antibacterial and Anti-inflammatory Capsules, is a generic OTC TCM that is administered as an antibiotic. Both products will enter markets with over $1 billion in sales each year. More details...
Stock Symbol: (NYSE Amex: TPI)


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital